Which stock wins in a head-to-head battle between these two medical device makers?
News & Analysis: Accuray
ARAY earnings call for the period ending September 30, 2019.
Accuray and Stereotaxis are hyper-focused on growth.
Disappointing fourth-quarter results are taking a toll on the medical device stock.
The CyberKnife maker missed Wall Street bottom-line estimates and announced disappointing guidance for fiscal 2020.
ARAY earnings call for the period ending June 30, 2019.
ARAY earnings call for the period ending March 31, 2019.
Which medical-device titan is more worthy of your investment dollars today?
Market turbulence couldn't stop these stocks from posting sizable gains.
Traders cheer a mixed earnings report. Here's what investors need to know.